Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Safety profile assessment of drug products used for the pathogenetic treatment of COVID-19.
Syraeva, G. I.; Mishinova, S. A.; Kolbin, A. S.; Eremenko, E. O..
Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia ; 23(3):314-329, 2021.
Article in Russian | EMBASE | ID: covidwho-2304451
2.
Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA;RWD)
Kolbin, A.; Syraeva, G. I.; Mishinova, S. A..
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research ; 25(7):S587-S587, 2022.
Article in English | EuropePMC | ID: covidwho-1904887
3.
A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine
Kolbin, A.; Mishinova, S. A.; Syraeva, G. I.; Polushin, Y. S..
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research ; 25(7):S593-S593, 2022.
Article in English | EuropePMC | ID: covidwho-1904886
4.
Safety profile assessment of drug products used for the pathogenetic treatment of COVID-19
Syraeva, G. I.; Mishinova, S. A.; Kolbin, A. S.; Eremenko, E. O..
Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia ; 23(3):314-329, 2021.
Article in Russian | Scopus | ID: covidwho-1772234
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL